Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmaceutical pricing conundrum: time to get rid of it?

Literature DB >> 30030646

Pharmaceutical pricing conundrum: time to get rid of it?

Livio Garattini¹, Anna Padula².

Abstract

Mesh：

Year: 2018 PMID： 30030646 DOI： 10.1007/s10198-018-0995-x

Source DB: PubMed Journal: Eur J Health Econ ISSN： 1618-7598

× No keyword cloud information.

26 in total

1. Probing Our Moral Values in Health Care: The Pricing of Specialty Drugs.

Authors: Uwe Reinhardt
Journal: JAMA Date: 2015-09-08 Impact factor: 56.272

2. Pharmaceutical Price Schemes in Europe: Time for a 'Continental' One?

Authors: Livio Garattini; Alessandro Curto; Nick Freemantle
Journal: Pharmacoeconomics Date: 2016-05 Impact factor: 4.981

3. Health technology assessment: for whom the bell tolls?

Authors: Livio Garattini; Gianluigi Casadei
Journal: Eur J Health Econ Date: 2008-11

4. Optional copayments on anti-cancer drugs.

Authors: Katelijne van de Vooren; Alessandro Curto; Livio Garattini
Journal: BMJ Date: 2013-01-24

5. 'Appropriateness' in Italy: A 'Magic Word' in Pharmaceuticals?

Authors: Livio Garattini; Anna Padula
Journal: Appl Health Econ Health Policy Date: 2017-02 Impact factor: 2.561

6. The puzzle of drug delivery in Italy: who wins?

Authors: Livio Garattini; Alessandro Curto; Anna Padula
Journal: Expert Rev Pharmacoecon Outcomes Res Date: 2016-05-03 Impact factor: 2.217

7. Reimbursable drug classes and ceilings in Italy: why not only one?

Authors: Livio Garattini; Alessandro Curto; Anna Padula
Journal: Eur J Health Econ Date: 2016-11

8. Research and Development Spending to Bring a Single Cancer Drug to Market and Revenues After Approval.

Authors: Vinay Prasad; Sham Mailankody
Journal: JAMA Intern Med Date: 2017-11-01 Impact factor: 21.873

Review 9. Essential medicines for universal health coverage.

Authors: Veronika J Wirtz; Hans V Hogerzeil; Andrew L Gray; Maryam Bigdeli; Cornelis P de Joncheere; Margaret A Ewen; Martha Gyansa-Lutterodt; Sun Jing; Vera L Luiza; Regina M Mbindyo; Helene Möller; Corrina Moucheraud; Bernard Pécoul; Lembit Rägo; Arash Rashidian; Dennis Ross-Degnan; Peter N Stephens; Yot Teerawattananon; Ellen F M 't Hoen; Anita K Wagner; Prashant Yadav; Michael R Reich
Journal: Lancet Date: 2016-11-08 Impact factor: 79.321

10. Bringing down the cost of cancer treatment.

Authors: Elie Dolgin
Journal: Nature Date: 2018-03-08 Impact factor: 49.962

5 in total

1. Comment on: 'The Impact of Hospital Costing Methods on Cost-Effectiveness Analysis: A Case Study'.

Authors: Livio Garattini; Anna Padula
Journal: Pharmacoeconomics Date: 2019-10 Impact factor: 4.981

2. Comment on: 'NICE, in Confidence: An Assessment of Redaction to Obscure Confidential Information in Single Technology Appraisals by the National Institute for Health and Care Excellence'.

Authors: Livio Garattini; Nicholas Freemantle
Journal: Pharmacoeconomics Date: 2020-01 Impact factor: 4.981